5.10 Amino Acids and the Brain: Precursors, Transport, and Neurotransmitter Synthesis

Executive summary. Most neurotransmitters are built from amino acids, and two of the most abundant — glutamate and GABA — are amino acids themselves. That makes the reasoning behind precursor supplementation superficially compelling: Supply more raw material, get more product. In practice three barriers intervene. Rate-limiting enzymes are normally close to saturated with substrate, six large neutral amino acids compete for a single transporter into the brain so that entry depends on ratios rather than absolute intake, and presynaptic feedback actively resists changes in transmitter availability. This article follows the chemistry properly, explains the transport competition that makes a high-protein meal capable of lowering brain tryptophan, and finishes with an honest audit of which amino acid interventions have human evidence behind them.

‌

Key takeaways

1. Tyrosine and phenylalanine build the catecholamines. Tryptophan builds serotonin and then melatonin. Glutamate and GABA are amino acids in their own right.
2. The rate-limiting enzymes — tyrosine hydroxylase and tryptophan hydroxylase — are normally close to saturated, so extra substrate yields far less extra product than intuition predicts.
3. Six large neutral amino acids share the LAT1 transporter into the brain. Brain entry is governed by the ratio of one to the others, not by absolute intake.
4. This is why a protein-rich meal can reduce brain tryptophan availability, and why carbohydrate raises it: Insulin drives branched-chain amino acids into muscle and reduces the competition.
5. Tyrosine shows modest benefit under acute stressors such as cold and sleep deprivation, and little at rest. BCAA supplementation to delay central fatigue is largely unsupported.
6. Creatine has the best evidence of anything in this chapter, and it works by energy buffering rather than as a neurotransmitter precursor.

‌

Beginner section: Raw materials are rarely the bottleneck

Here is the idea that sells a great many supplements. Serotonin is made from tryptophan. Turkey contains tryptophan. Therefore eating turkey should raise serotonin and improve your mood. Every step in that chain is true except the conclusion.

‌

The problem is that biology is full of bottlenecks that are not the raw material. Two matter here.

‌

The first is the enzyme. Converting tryptophan into serotonin requires an enzyme called tryptophan hydroxylase, and converting tyrosine into dopamine requires tyrosine hydroxylase. Both are normally working close to their maximum capacity with respect to how much substrate they have available (Fernstrom & Fernstrom, 2007). Adding more raw material to an enzyme that is already saturated produces very little extra product, in the same way that delivering more flour to a bakery whose ovens are already full does not produce more bread.

‌

The second is the door. Amino acids cannot simply drift into your brain. They are carried across the blood-brain barrier by transporters, and six of the important ones all share the same transporter (Pardridge, 1998). They compete. This has a genuinely counterintuitive consequence.

‌

‌

Read that figure carefully. After a high-protein meal your blood tryptophan goes up — and the amount reaching your brain goes down, because the competing amino acids went up more and crowded it out at the door (Fernstrom & Wurtman, 1972). After a carbohydrate-rich meal the opposite happens, because insulin pulls the branched-chain amino acids into muscle and clears the queue.

‌

‌

So the honest beginner-level summary is this. Eat enough total protein for your training, because that matters for a great many reasons. Do not expect individual amino acids to work as mood or focus dials, because the system is specifically built to resist that.

‌

Advanced section: The chemistry, the transporter, and the evidence

Which amino acids become which signals

Only a small subset of the twenty amino acids are direct neurotransmitter precursors, and it is worth knowing which.

‌

‌

• Tyrosine to catecholamines. Tyrosine hydroxylase converts tyrosine to L-DOPA, which DOPA decarboxylase converts to dopamine. In noradrenergic neurons dopamine beta-hydroxylase then produces noradrenaline, and in the adrenal medulla a further methylation produces adrenaline. Tyrosine can itself be made from phenylalanine, which is why phenylalanine is an indirect precursor (Fernstrom & Fernstrom, 2007).
• Tryptophan to serotonin and melatonin. Tryptophan hydroxylase produces 5-hydroxytryptophan, which is decarboxylated to serotonin. In the pineal gland serotonin is further converted to melatonin, which is the biochemical link between this chapter and the circadian material in Article 5.17. Importantly, the great majority of tryptophan metabolism actually proceeds down the kynurenine pathway rather than to serotonin (Schwarcz et al., 2012).
• Glutamate and GABA. Glutamate is synthesised in the brain largely from glutamine supplied by astrocytes, in the glutamate-glutamine cycle. Glutamic acid decarboxylase then converts glutamate to GABA. Because dietary glutamate crosses the blood-brain barrier poorly, brain glutamate is essentially locally produced (Pardridge, 1998).
• Histidine and glycine. Histidine is decarboxylated to histamine, used by tuberomammillary neurons for wakefulness. Glycine is itself an inhibitory transmitter, particularly in the spinal cord and brainstem, and is also a co-agonist at the NMDA receptor.

‌

‌

The transporter, and why ratios beat amounts

Large neutral amino acids cross the blood-brain barrier via a sodium-independent carrier, system L, of which LAT1 is the relevant isoform at the endothelium. Tryptophan, tyrosine, phenylalanine, leucine, isoleucine and valine all use it, and the carrier is close to saturated at normal plasma concentrations (Pardridge, 1998; Boado et al., 1999).

‌

‌

The consequence, first characterised in detail by Fernstrom and Wurtman, is that brain uptake of any one of these depends on its plasma concentration divided by the sum of its competitors (Fernstrom & Wurtman, 1972). This produces two effects that surprise people.

‌

1. A carbohydrate meal raises brain tryptophan. Insulin promotes uptake of branched-chain amino acids into skeletal muscle, which lowers the denominator, which raises the ratio, which raises tryptophan entry — despite carbohydrate containing no tryptophan at all (Fernstrom & Wurtman, 1972).
2. A protein meal can lower brain tryptophan. Protein supplies tryptophan but supplies proportionally much more of its competitors, particularly the branched-chain amino acids, so the ratio falls.

‌

This is also the mechanistic origin of the “central fatigue” hypothesis for prolonged endurance exercise. During long exercise, free fatty acids rise and displace tryptophan from albumin while branched-chain amino acids are oxidised, both of which raise the free tryptophan to BCAA ratio and would be expected to increase brain serotonin (Newsholme & Blomstrand, 2006). The proposal was that this contributes to the perception of fatigue, and that BCAA supplementation should therefore delay it.

‌

The hypothesis is elegant and the intervention largely does not work. Controlled trials of BCAA supplementation have generally failed to show meaningful endurance performance benefit, and reviews of central fatigue have moved towards multi-transmitter accounts, notably involving the serotonin to dopamine ratio rather than serotonin alone (Meeusen et al., 2006). This is a good example of a mechanism being real while the intervention built on it is ineffective.

‌

‌

What the human evidence supports

Separating mechanism from outcome is the whole task in this area.

‌

‌

• Tyrosine. The most defensible of the precursor interventions, and still modest. Trials suggest cognitive protection under acute stressors including cold exposure, sleep deprivation and multitasking load, consistent with catecholamine synthesis becoming substrate-limited only when demand is unusually high (Deijen & Orlebeke, 1994; Jongkees et al., 2015). Evidence for benefit in rested, well-fed people performing ordinary tasks is weak. It is not an ergogenic aid for strength or endurance.
• Tryptophan and 5-HTP. These do raise serotonin synthesis, which is precisely why they are not casual supplements. Combining them with serotonergic medication carries a genuine risk of serotonin syndrome, and 5-HTP bypasses the rate-limiting enzyme entirely. Any use should be a clinical decision.
• BCAAs. Widely sold for central fatigue on the basis of the transport competition described above. Performance evidence does not support the claim, and BCAAs also compete with tyrosine for entry, so the theoretical picture is not straightforwardly favourable either.
• Creatine. Not a neurotransmitter precursor, but the amino-acid-derived compound with the best cognitive evidence. Brain creatine supports phosphocreatine-based energy buffering, and supplementation has shown small but reasonably consistent effects on cognitive tasks, with the clearest signals under sleep deprivation or otherwise stressed conditions (Rae et al., 2003; Avgerinos et al., 2018). Doses used for cognition in research are often higher than standard strength-training doses.
• Glutamine and GABA. Oral glutamine is largely taken up by the gut and does not reliably raise brain glutamate, which is a good thing. Oral GABA crosses the blood-brain barrier poorly and evidence for central effects at supplement doses is weak.

‌

A note on safety that matters more here than in most chapters. Amino acids are not inert. High-dose single amino acids can alter the balance of others, several interact with medications, and tryptophan-pathway supplements in particular have meaningful interaction risk. Discuss any of this with a doctor or dietitian who knows your medications rather than reasoning from mechanism.

‌

‌

Practical section: What to actually do about food and timing

Very little of this chapter converts into supplement recommendations. Most of it converts into unremarkable dietary competence, which is a more useful outcome.

‌

• Meet total protein needs first. Adequate total protein makes precursor availability a non-issue for a healthy athlete. Chasing individual amino acids while total intake is inadequate is the wrong order of operations.
• Use carbohydrate timing for sleep, not for mood. The tryptophan ratio effect is real but modest. A carbohydrate-containing evening meal is a reasonable, low-cost thing to try if sleep onset is difficult; it is not a treatment for anything.
• Do not expect a pre-training protein shake to sharpen focus. It raises the competitors as much as the precursors. If you want alertness before a session, the levers are sleep, caffeine and warm-up design.
• Consider creatine on its own merits. It has the best evidence in this chapter, for both muscle and cognition, and a long safety record in healthy adults at standard doses. As with anything, check with a clinician if you have kidney concerns or take medication.
• Be sceptical of “mood” amino acid blends. Most rely on the precursor reasoning this chapter dismantles, and several contain ingredients with real interaction risk.
• Treat persistent low mood as clinical. If mood or drive is persistently low, the productive step is assessment, not a precursor stack.

‌

It is worth stating the general lesson explicitly, because it generalises well beyond amino acids. When a system has a saturated enzyme, a competitive transporter and feedback inhibition, it has three separate mechanisms whose job is to keep the output stable regardless of input. That is a strong hint that the input is not the lever you are looking for.

‌

‌

Sport applications

• Endurance events over three hours. The central fatigue mechanism is real, the BCAA intervention is not effective, and carbohydrate feeding remains the intervention with actual evidence for both peripheral and central reasons.
• Weight-class sports in a deficit. Low energy availability affects mood, sleep and drive well before it affects strength. Protein and total energy are the levers, not precursor supplements.
• Sports with heat or cold exposure. The tyrosine literature is strongest under exactly these acute stressors, so this is the narrow situation where it is worth discussing with a sports dietitian.
• Team sports with congested fixtures. Repeated sleep restriction is the dominant variable, and creatine is the compound with the best evidence for cognitive protection under sleep loss.
• Vegan and vegetarian athletes. Lower baseline creatine stores mean creatine supplementation tends to produce larger effects, and total protein adequacy deserves more attention rather than individual amino acid targeting.

‌

Common mistakes

• Assuming more precursor gives more transmitter. Saturated enzymes, competitive transport and feedback inhibition all exist to prevent exactly that.
• Taking protein to boost serotonin. Protein lowers the tryptophan-to-competitor ratio, so the effect on brain tryptophan is the opposite of what is intended.
• Using BCAAs to delay central fatigue. The mechanism is real but the intervention has not delivered in controlled trials, and BCAAs also crowd out tyrosine.
• Treating 5-HTP as a mild supplement. It bypasses the rate-limiting enzyme and carries genuine interaction risk with serotonergic medication.
• Expecting oral GABA to be calming. It crosses the blood-brain barrier poorly, and the evidence for central effects at supplement doses is weak.
• Optimising amino acids while under-eating overall. Total energy and protein adequacy dominate every effect described in this article.

‌

Coaching cues

• Get total protein right before thinking about any single amino acid.
• Remember that ratios, not amounts, determine what reaches the brain.
• Carbohydrate in the evening is a reasonable sleep experiment, not a treatment.
• If a supplement claim rests only on “X is made from Y”, treat it as unproven.
• Creatine is the one with real evidence here. Judge it on that, not on precursor logic.
• Check interactions with a clinician before any tryptophan-pathway supplement.

‌

FAQs

Does eating turkey make you sleepy because of tryptophan?

Almost certainly not by that mechanism. Turkey is not unusually high in tryptophan compared with other protein foods, and because protein raises the competing large neutral amino acids proportionally more, a protein-rich meal tends to lower rather than raise brain tryptophan availability. Post-meal sleepiness is better explained by meal size, carbohydrate content, alcohol and the time of day.

‌

Should I take tyrosine before training?

For ordinary training in a rested, well-fed state, the evidence does not support a benefit. The trials showing effects have generally used acute stressors such as cold exposure, sleep deprivation or heavy multitasking, which is consistent with catecholamine synthesis becoming substrate-limited only under unusual demand. If you compete in extreme heat or cold, or under severe sleep restriction, it is a reasonable thing to raise with a sports dietitian.

‌

Do BCAAs reduce fatigue in long events?

The theory is that BCAAs compete with tryptophan for brain entry and so limit the rise in brain serotonin during prolonged exercise. The theory is sound; the intervention has not held up. Controlled trials have largely failed to demonstrate meaningful endurance benefit, and current accounts of central fatigue emphasise the balance between several transmitters rather than serotonin alone. Carbohydrate remains the better-evidenced intervention.

‌

Is creatine actually good for the brain?

The evidence is better than for anything else in this chapter, though the effects are small. Brain creatine contributes to phosphocreatine energy buffering, and supplementation trials have shown modest improvements on some cognitive measures, with the clearest effects under sleep deprivation or other stress. Effects tend to be larger in people with lower baseline stores, including vegetarians. It is not a nootropic in the dramatic sense, and it is worth checking with a clinician if you have kidney disease or take relevant medication.

‌

Can I raise GABA by taking a GABA supplement?

Not reliably. Orally ingested GABA crosses the blood-brain barrier poorly, and human evidence for meaningful central effects at typical supplement doses is weak and inconsistent. Reported calming effects are more plausibly peripheral or expectancy-driven.

‌

Does most tryptophan become serotonin?

No, and this is often left out. The large majority of tryptophan metabolism proceeds down the kynurenine pathway, which is also relevant to inflammation and to some accounts of exercise and mood, rather than to serotonin synthesis. Serotonin synthesis accounts for a small fraction of total tryptophan use.

‌

Recommended videos

Each video below was chosen because it covers a specific part of this article in more depth than text alone allows.

‌

‌

‌

‌

‌

‌

Related reading on FitXplor

• 5.6 Neurotransmitters and Neuromodulators
• 5.7 The Dopamine System
• 5.9 Serotonin, Noradrenaline, and Acetylcholine
• 1.4 Exercise Physiology and Energy Systems
• 1.7 Recovery Science and Adaptation

‌

References

Fernstrom, J. D., & Wurtman, R. J. (1972). Brain serotonin content: physiological regulation by plasma neutral amino acids. Science, 178(4059), 414–416.

Fernstrom, J. D., & Fernstrom, M. H. (2007). Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. The Journal of Nutrition, 137(6 Suppl 1), 1539S–1547S.

Pardridge, W. M. (1998). Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochemical Research, 23(5), 635–644.

Boado, R. J., Li, J. Y., Nagaya, M., Zhang, C., & Pardridge, W. M. (1999). Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proceedings of the National Academy of Sciences, 96(21), 12079–12084.

Newsholme, E. A., & Blomstrand, E. (2006). Branched-chain amino acids and central fatigue. The Journal of Nutrition, 136(1 Suppl), 274S–276S.

Meeusen, R., Watson, P., Hasegawa, H., Roelands, B., & Piacentini, M. F. (2006). Central fatigue: the serotonin hypothesis and beyond. Sports Medicine, 36(10), 881–909.

Deijen, J. B., & Orlebeke, J. F. (1994). Effect of tyrosine on cognitive function and blood pressure under stress. Brain Research Bulletin, 33(3), 319–323.

Jongkees, B. J., Hommel, B., Kühn, S., & Colzato, L. S. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: a review. Journal of Psychiatric Research, 70, 50–57.

Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003). Oral creatine monohydrate supplementation improves brain performance. Proceedings of the Royal Society B, 270(1529), 2147–2150.

Avgerinos, K. I., Spyrou, N., Bougioukas, K. I., & Kapogiannis, D. (2018). Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Experimental Gerontology, 108, 166–173.

Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012). Kynurenines in the mammalian brain: when physiology meets pathology. Nature Reviews Neuroscience, 13(7), 465–477.

Boldyrev, A. A., Aldini, G., & Derave, W. (2013). Physiology and pathophysiology of carnosine. Physiological Reviews, 93(4), 1803–1845.